Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that they will provide an extra 100 million doses of its Comirnaty COVID-19 vaccine to EU member countries in 2021.
“In partnership with the European Commission, member states and healthcare providers, we will be able to reach a total of 150 million Europeans across the continent,” Pfizer CEO Albert Bourla said in a news release.
The announcement comes a week after Pfizer announced an extra 100 million doses for the U.S.
The EU is now set to receive a total 300 million doses of Comirnaty; the U.S. will receive 200 million. Pfizer and BioNTech have previously said they expect to manufacture up to 1.3 billion doses worldwide by the end of 2021.
Tell Us What You Think!